Tag: pediatric drug studies

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (12)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image Preventing & Managing Workplace Sprains: Practical Tips for Employers and Employees
recent-post-image Zyprexa (Olanzapine) vs Common Antipsychotic Alternatives - Detailed Comparison
recent-post-image Sorrel Supplement: Healing Benefits and Why It Belongs in Your Daily Routine
recent-post-image Severe Hyponatremia from Medications: Warning Signs, Causes, and Immediate Care
recent-post-image Opioid Itching vs. Allergy: How to Tell the Difference and What to Do

Menu

© 2025. All rights reserved.